Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05201534 · ClinicalTrials.gov registry record · NA
Interventions in Mathematics and Cognitive Skills
A NA study of Child Development and Developmental Disability, sponsored by Stanford University.
- Recruiting
- Registry status
- NA
- Development phase
- 180
- Enrollment target
- 1
- Study location
NCT05201534: Recruiting NA study of Child Development and Developmental Disability, sponsored by Stanford University.
NCT05201534 is a NA study of Child Development and Developmental Disability that is actively recruiting participants, run by Stanford University. The registered enrollment target is 180 participants, below the 1,088-participant average among 32 other Child Development trials with a reported enrollment target (83% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05201534, a NA study of Child Development and Developmental Disability, is actively recruiting participants, sponsored by Stanford University.
- RECRUITING
- Registry status
- NA
- Development phase
- 180 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate neurocognitive mechanisms underlying response to intervention aimed at enhancing, and remediating weaknesses in, numerical skills in children, including those with mathematical learning disabilities (MLD).
Primary Outcome
Performance will be measured by children's reaction time (milliseconds) on symbolic number comparison task
Conditions Studied
Interventions
- OTHER Interventions in Mathematics and Cognitive Skills - Experimental
- OTHER Interventions in Mathematics and Cognitive Skills - Active Comparator
Study Locations (1)
California
- Stanford Cognitive and Systems Neuroscience Laboratory - Palo Alto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 180 participants |
| Start Date | 2023-05-05 |
| Est. Completion | 2026-06-30 |
| Phase | NA |
What NCT05201534 shows while recruiting
NCT05201534 is an interventional study that assigns participants to a tested intervention. The registered 180 participants enrollment target is mid-sized for trials with a published cap, below the 1,088-participant average among 32 other Child Development trials with a reported enrollment target (83% lower).
The record links to 10 conditions, with Child Development appearing as the primary indexed condition, and to 2 interventions - of which Interventions in Mathematics and Cognitive Skills - Experimental is the first listed.
NCT05201534 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT05201534 about?
NCT05201534 is a clinical study titled "Interventions in Mathematics and Cognitive Skills". The purpose of this study is to investigate neurocognitive mechanisms underlying response to intervention aimed at enhancing, and remediating weaknesses in, numerical skills in children, including those with mathematical learning disabilities (MLD).
What is the current status of trial NCT05201534?
This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2023-05-05. Estimated completion is 2026-06-30.
What conditions does trial NCT05201534 study?
This clinical trial studies the following conditions: Child Development, Developmental Disability, Math Learning Disability, Learning Disabilities, Learning Disabled.
What interventions are being tested in trial NCT05201534?
The interventions under investigation include: Interventions in Mathematics and Cognitive Skills - Experimental (OTHER), Interventions in Mathematics and Cognitive Skills - Active Comparator (OTHER).
Who is sponsoring clinical trial NCT05201534?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05201534 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Child Development
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05201534's enrollment target sits among peer trials
180 19th of 32 higher than 14 of 32 other Child Development trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Child Development trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants
RECRUITING · NA
-
PRT for Adolescents With High Functioning Autism
RECRUITING · NA
-
A Mobile Health Intervention to Reduce Sweet Beverage Consumption in Latino Children
RECRUITING · NA
-
CenteringParenting Clinical Intervention on Kindergarten Readiness in Early Childhood
RECRUITING · NA
-
Promoting Health Through Play Program: Improving Parent and Child Outcomes
RECRUITING · NA
-
Impact Trial of Helping Educational Leaders Mobilize Evidence
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01558804 · 180 participants
GRoup A StrePtococcus
- NCT02932176 · 180 participants
Machine Learning for Handheld Vascular Studies
- NCT03384563 · 180 participants · Phase 4
Effect of Dexmedetomidine on the Minimum Alveolar Concentration of Sevoflurane
- NCT03423628 · 180 participants · Phase 1
A Study to Assess the Safety and Tolerability of AZD1390 Given With Radiation Therapy in Patients With Brain Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI